Brazilian researchers conducted a study comparing two treatments for postoperative endophthalmitis. They found that pars ...
1d
Clinical Trials Arena on MSNUnity reports topline outcomes from trial of diabetic macular oedema therapyUnity Biotechnology has reported outcomes from its randomised Phase IIb ASPIRE study of intravitreal UBX1325 for diabetic ...
15d
Amazon S3 on MSNIntravitreal Injections - The ProcedureDr. Amit Gupta, MD, FACS, Ophthalmologist, talks about the steps involved and potential side effects when getting an intravitreal injection.
16d
Amazon S3 on MSNHow Often Are Intravitreal Injections Needed?Dr. Amit Gupta, MD, FACS, Ophthalmologist, talks about how often and how long intravitreal injections are typically needed.
8d
Clinical Trials Arena on MSNOcugen receives DSMB approval to continue dosing in Phase I trial of OCU200Ocugen has received approval from the DSMB to begin dosing the second cohort of patients in a trial of OCU200 for diabetic ...
Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of ...
UNITY Biotechnology (UBX) announced topline results from the Phase 2b ASPIRE clinical trial of intravitreal UBX1325 in patients with diabetic ...
Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real ...
Harrow, Inc. stock dropped 50% post Q3 2024, but Q4 previews and FY 2025 projections signal growth potential. Click here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results